BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 29992578)

  • 1. GPRC5A deficiency leads to dysregulated MDM2 via activated EGFR signaling for lung tumor development.
    Song H; Sun B; Liao Y; Xu D; Guo W; Wang T; Jing B; Hu M; Li K; Yao F; Deng J
    Int J Cancer; 2019 Feb; 144(4):777-787. PubMed ID: 29992578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung Tumor Suppressor GPRC5A Binds EGFR and Restrains Its Effector Signaling.
    Zhong S; Yin H; Liao Y; Yao F; Li Q; Zhang J; Jiao H; Zhao Y; Xu D; Liu S; Song H; Gao Y; Liu J; Ma L; Pang Z; Yang R; Ding C; Sun B; Lin X; Ye X; Guo W; Han B; Zhou BP; Chin YE; Deng J
    Cancer Res; 2015 May; 75(9):1801-14. PubMed ID: 25744720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gprc5a-knockout mouse lung epithelial cells predicts ceruloplasmin, lipocalin 2 and periostin as potential biomarkers at early stages of lung tumorigenesis.
    Sun B; Guo W; Hu S; Yao F; Yu K; Xing J; Wang R; Song H; Liao Y; Wang T; Jiang P; Han B; Deng J
    Oncotarget; 2017 Feb; 8(8):13532-13544. PubMed ID: 28088789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Active Bronchioalveolar Stem Cells as the Cell of Origin in Lung Adenocarcinoma.
    Yin H; Jing B; Xu D; Guo W; Sun B; Zhang J; Liao Y; Song H; Wang T; Liu S; Kuang Y; Hu M; Li K; Zhang S; Zhang H; Xu J; Li X; Du J; Wu Y; Wu Y; Wang Q; Yao F; Chin YE; Zhou BP; Deng J
    Cancer Res; 2022 Mar; 82(6):1025-1037. PubMed ID: 35045987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of DYRK1A-EGFR axis by p53-MDM2 cascade mediates the induction of cellular senescence.
    Xu X; Liu Q; Zhang C; Ren S; Xu L; Zhao Z; Dou H; Li P; Zhang X; Gong Y; Shao C
    Cell Death Dis; 2019 Mar; 10(4):282. PubMed ID: 30910997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of MDM2 and vascular endothelial growth factor inhibition on tumor angiogenesis and metastasis in neuroblastoma.
    Patterson DM; Gao D; Trahan DN; Johnson BA; Ludwig A; Barbieri E; Chen Z; Diaz-Miron J; Vassilev L; Shohet JM; Kim ES
    Angiogenesis; 2011 Sep; 14(3):255-66. PubMed ID: 21484514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the retinoic acid-inducible Gprc5a as a new lung tumor suppressor gene.
    Tao Q; Fujimoto J; Men T; Ye X; Deng J; Lacroix L; Clifford JL; Mao L; Van Pelt CS; Lee JJ; Lotan D; Lotan R
    J Natl Cancer Inst; 2007 Nov; 99(22):1668-82. PubMed ID: 18000218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDM2 overexpression deregulates the transcriptional control of RB/E2F leading to DNA methyltransferase 3A overexpression in lung cancer.
    Tang YA; Lin RK; Tsai YT; Hsu HS; Yang YC; Chen CY; Wang YC
    Clin Cancer Res; 2012 Aug; 18(16):4325-33. PubMed ID: 22733537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy.
    Tovar C; Rosinski J; Filipovic Z; Higgins B; Kolinsky K; Hilton H; Zhao X; Vu BT; Qing W; Packman K; Myklebost O; Heimbrook DC; Vassilev LT
    Proc Natl Acad Sci U S A; 2006 Feb; 103(6):1888-93. PubMed ID: 16443686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EGFR phosphorylates and inhibits lung tumor suppressor GPRC5A in lung cancer.
    Lin X; Zhong S; Ye X; Liao Y; Yao F; Yang X; Sun B; Zhang J; Li Q; Gao Y; Wang Y; Liu J; Han B; Chin YE; Zhou BP; Deng J
    Mol Cancer; 2014 Oct; 13():233. PubMed ID: 25311788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gprc5a-deficiency confers susceptibility to endotoxin-induced acute lung injury via NF-κB pathway.
    Liao Y; Song H; Xu D; Jiao H; Yao F; Liu J; Wu Y; Zhong S; Yin H; Liu S; Wang X; Guo W; Sun B; Han B; Chin YE; Deng J
    Cell Cycle; 2015; 14(9):1403-12. PubMed ID: 25714996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of MDM2 inhibitors on vascular endothelial growth factor-mediated tumor angiogenesis in human breast cancer.
    Xiong J; Yang Q; Li J; Zhou S
    Angiogenesis; 2014 Jan; 17(1):37-50. PubMed ID: 23907365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTGES/PGE
    Wang T; Jing B; Xu D; Liao Y; Song H; Sun B; Guo W; Xu J; Li K; Hu M; Liu S; Ling J; Kuang Y; Zhang T; Zhang S; Yao F; Zhou BP; Deng J
    Oncogene; 2020 Apr; 39(15):3179-3194. PubMed ID: 32060421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gprc5a deletion enhances the transformed phenotype in normal and malignant lung epithelial cells by eliciting persistent Stat3 signaling induced by autocrine leukemia inhibitory factor.
    Chen Y; Deng J; Fujimoto J; Kadara H; Men T; Lotan D; Lotan R
    Cancer Res; 2010 Nov; 70(21):8917-26. PubMed ID: 20959490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting MDM2-p53 Interaction Suppresses Tumor Growth in Patient-Derived Non-Small Cell Lung Cancer Xenograft Models.
    Hai J; Sakashita S; Allo G; Ludkovski O; Ng C; Shepherd FA; Tsao MS
    J Thorac Oncol; 2015 Aug; 10(8):1172-80. PubMed ID: 26200271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of GPRC5A expression in colorectal cancer promotes tumor progression through VNN-1 induced oxidative stress.
    Zhang L; Li L; Gao G; Wei G; Zheng Y; Wang C; Gao N; Zhao Y; Deng J; Chen H; Sun J; Li D; Zhang X; Liu M
    Int J Cancer; 2017 Jun; 140(12):2734-2747. PubMed ID: 28316092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent in vitro and in vivo antitumor effects of MDM2 inhibitor nutlin-3 in gastric cancer cells.
    Endo S; Yamato K; Hirai S; Moriwaki T; Fukuda K; Suzuki H; Abei M; Nakagawa I; Hyodo I
    Cancer Sci; 2011 Mar; 102(3):605-13. PubMed ID: 21205074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lung cancer suppressor gene GPRC5A mediates p53 activity in non‑small cell lung cancer cells in vitro.
    Jin E; Wang W; Fang M; Wang L; Wu K; Zhang Y; Zhang S; Ma S
    Mol Med Rep; 2017 Nov; 16(5):6382-6388. PubMed ID: 28849235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial neoplasia coincides with exacerbated injury and fibrotic response in the lungs of Gprc5a-knockout mice following silica exposure.
    Wang X; Xu D; Liao Y; Zhong S; Song H; Sun B; Zhou BP; Deng J; Han B
    Oncotarget; 2015 Nov; 6(37):39578-93. PubMed ID: 26447616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity.
    Sriraman A; Radovanovic M; Wienken M; Najafova Z; Li Y; Dobbelstein M
    Oncotarget; 2016 May; 7(22):31623-38. PubMed ID: 27183917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.